RENA ALI: Open Payments
NPI 1679116966 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,852 in 36 payments from 18 companies in 2025. Trend: 2023 $1,224 · 2024 $3,055 · 2025 $3,852
Food & beverage: $3,852
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $714 |
| ABBVIE INC. | 5 | $506 |
| Phathom Pharmaceuticals, Inc. | 2 | $288 |
| Ardelyx, Inc. | 3 | $254 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $241 |
| Novo Nordisk Inc | 2 | $233 |
| Amgen Inc. | 2 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $225 |
| ViiV Healthcare Company | 2 | $209 |
| COLOPLAST CORP | 2 | $155 |
Products named: REZDIFFRA, VOQUEZNA, VRAYLAR, IBSRELA, JARDIANCE, CAPLYTA, APRETUDE, Attruby.
Industry payments across IL — which companies pay providers there.
